Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
2022 · JAMA Network Open · 322 citations
https://doi.org/10.1001/jamanetworkopen.2022.32760
S
Sarah A. Buchan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
209
Papers
5.2K
Citations
37
h-index
93
i10-index
Sarah A. Buchan is an academic researcher from Toronto Public Health. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Respiratory viral infections research & Influenza Virus Research Studies. The author has an h-index of 37, co-authored 178 publications.
ORCID: 0000-0002-5286-8974Papers by this author
worksSystematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave
2016 · BMJ Global Health · 144 citations
https://doi.org/10.1136/bmjgh-2015-000004
RETRACTED ARTICLE:The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis
2017 · BMC Medicine · 37 citations
https://doi.org/10.1186/s12916-017-0919-0
Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial
2024 · BMJ · 18 citations
https://doi.org/10.1136/bmj-2023-078243
Population immunity to measles in Canada using Canadian Health Measures survey data – A Canadian Immunization Research Network (CIRN) study
2022 · Vaccine · 11 citations
https://doi.org/10.1016/j.vaccine.2022.04.011
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection
2024 · Heliyon · 5 citations
https://doi.org/10.1016/j.heliyon.2024.e26551
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat